While Pliant Therapeutics Inc has overperformed by 2.29%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PLRX fell by -90.71%, with highs and lows ranging from $16.52 to $1.24, whereas the simple moving average fell by -87.42% in the last 200 days.
On March 04, 2025, Cantor Fitzgerald started tracking Pliant Therapeutics Inc (NASDAQ: PLRX) recommending Neutral. A report published by Needham on March 04, 2025, Downgraded its rating to ‘Hold’ for PLRX. Wells Fargo February 10, 2025d its ‘Overweight’ rating to ‘Equal Weight’ for PLRX, as published in its report on February 10, 2025. RBC Capital Mkts’s report from February 10, 2025 suggests a price prediction of $4 for PLRX shares, giving the stock a ‘Sector Perform’ rating. Oppenheimer also rated the stock as ‘Perform’.
Analysis of Pliant Therapeutics Inc (PLRX)
To gain a thorough understanding of Pliant Therapeutics Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -54.09% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 10.91, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and PLRX is recording an average volume of 2.67M. On a monthly basis, the volatility of the stock is set at 9.16%, whereas on a weekly basis, it is put at 9.12%, with a loss of -8.84% over the past seven days. Furthermore, long-term investors anticipate a median target price of $4.79, showing growth from the present price of $1.34, which can serve as yet another indication of whether PLRX is worth investing in or should be passed over.
How Do You Analyze Pliant Therapeutics Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 13.46%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 100.15% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
PLRX shares are owned by institutional investors to the tune of 100.15% at present.
